Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-30

FDA Approved: BUMETANIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

FDA approved Bumetanide as a generic via Original Application (ANDA 202900), confirming bioequivalence to the reference product. It is indicated for edema assoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

ORIG AP for BUMETANIDE (BUMETANIDE)